Press Release: Successful Acquisition of PAPmed GmbH by Arsipa - CARL Acts as Exclusive Advisor
Berlin, 09.09.2025 – CARL Finance GmbH (“CARL”), a leading M&A advisory firm for the German mid-market, proudly announces the successful completion of a strategically significant transaction: the sale of PAPmed GmbH (“PAPmed”) to Arsipa, a portfolio company of the private equity firm Warburg Pincus. This acquisition offers PAPmed the opportunity to enter a new growth phase and significantly strengthen its position in the field of occupational health services. Arsipa will benefit from PAPmed’s established market presence and, by investing in the development of its services, create additional value for the company’s clients.
About PAPmed:
PAPmed GmbH was founded in Berlin in 2012 and specializes in occupational health services. With locations in Berlin, Rostock, and Weißenfels, the company offers tailored solutions in health protection and occupational safety for businesses across various industries. PAPmed enjoys an excellent reputation for its customized services and sustainable health strategies.
Role of CARL:
CARL acted as the exclusive advisor on the seller's side, leading a structured and goal-oriented sales process. Thanks to its extensive expertise in the healthcare sector and deep market understanding, CARL was able to optimally position PAPmed in the investor market through careful analysis and targeted preparation. PAPmed's clear equity story generated broad international interest. CARL conducted negotiations with specialized M&A advisory skills, achieving an outstanding result for all parties involved.
Transaction Objective and Outcome:
The main objective of this transaction was to find a partner who values PAPmed's existing market position and ensures a sustainable succession solution. Arsipa was identified as a strategic partner with not only the necessary financial strength but also a clear vision for PAPmed’s further development. The management team, consisting of Dr. Michael Wendorf and Dr. Michael Schmitz-Rode, will continue to lead the company into its next growth phase.
Statement from PAPmed:
"The collaboration with CARL Finance during the sale of our company was impressive. The team handled the entire sales process excellently and guided us, as founders, through this complex endeavor. We could never have achieved this on our own. The team’s deep understanding of the healthcare sector and the specific requirements of us as doctors was especially impressive. The collaboration was not only professional but also incredibly enjoyable on a personal level. As entrepreneurs and physicians, we warmly recommend CARL Finance," emphasize Dr. Michael Wendorf and Dr. Michael Schmitz-Rode.
Statement from CARL:
"We are proud to have successfully supported PAPmed in this strategically significant transaction," says Daniel Schenk, CEO of CARL Finance. "Our work contributed to finding a partner who shares the vision and potential of PAPmed, and we are pleased that Arsipa, through this acquisition, will further strengthen its position in the German occupational health services market," adds Tamara Heinzle, Analyst at CARL Finance.
Outlook:
With the successful completion of this transaction, CARL Finance strengthens its position as a leading advisor in the German mid-market, particularly in the healthcare sector. CARL looks forward to supporting future successful transactions and creating added value for its clients.
M&A Advisors:
Daniel Schenk (CARL), Tamara Heinzle (CARL), Fryderyk Dudzinski (CARL)
Legal Advisors: Dr. Martin Schäfer (Schäfer Legal)